87 related articles for article (PubMed ID: 14028230)
1. [Treatment with phenyl-propyl-diphenyl-propyl-amine (Segontin Hoechst) in coronary disease].
DOBREANU-ENESCU V; TEODORINI S; HARNAGEA P
Stud Cercet Med Interna; 1963; 4():243-53. PubMed ID: 14028230
[No Abstract] [Full Text] [Related]
2. [3'-phenyl-propyl-(2')]-1, 1-diphenyl-propyl-(3)-amine (Segontin).
MALTEZ JS
J Med (Oporto); 1963 Jan; 50():189-202. PubMed ID: 13932641
[No Abstract] [Full Text] [Related]
3. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
FRANZINI C; TURRI C; MONTEROSSO A
Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
[No Abstract] [Full Text] [Related]
4. [Clinical and electrocardiographic considerations on the use of a new synthesis (phenyl-propyl-diphenyl-propyl-amine) in the therapy of syndromes of coronary insufficiency in urologic patients].
DE IASI A
Minerva Med; 1963 Apr; 54():1212-7. PubMed ID: 14025812
[No Abstract] [Full Text] [Related]
5. [Clinical and electrocardiographic observations on the treatment of coronary insufficiency with phenyl-propyl-diphenyl-propylamine].
ANSELMINO A; MILONE PA
Minerva Med; 1963 Apr; 54():1206-12. PubMed ID: 14013283
[No Abstract] [Full Text] [Related]
6. [Phenyl-propyl-diphenyl-propylamine in treatment of coronary insufficiency (clinical observations)].
Forattini C; Franceschi D
Minerva Cardioangiol; 1965 Aug; 13(8):477-83. PubMed ID: 5321977
[No Abstract] [Full Text] [Related]
7. [A new synthetic substance in the therapy of angina pectoris, N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
BAROCELLI C
Minerva Med; 1963 Apr; 54():1202-6. PubMed ID: 13969419
[No Abstract] [Full Text] [Related]
8. [Observations on the subject of clinical experimentation of a new synthetic antianginal compound: N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
MATANO F; ROMANO V
Minerva Med; 1963 Apr; 54():1193-9. PubMed ID: 13933526
[No Abstract] [Full Text] [Related]
9. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
ZOLI A; BRAT A; GIARDINA A
Riv Crit Clin Med; 1963 Apr; 63():75-90. PubMed ID: 14277814
[No Abstract] [Full Text] [Related]
10. [CLINICAL TRIALS WITH PHENYL-DIPHENYL-PROPYL-AMINE IN CORONARY INSUFFICIENCY].
TRILLA SANCHEZ E; BELLONCANEIRO JM; TORNER SOLER M
Rev Esp Cardiol; 1963 Oct; 16():873-84. PubMed ID: 14117507
[No Abstract] [Full Text] [Related]
11. [CONSIDERATIONS ON THE THERAPY OF CORONARY INSUFFICIENCY WITH PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (FPDPA)].
RIZZI R; BOZZA G; CESARI A; PASSERELLI A; VANGELISTA A
Gazz Int Med Chir; 1964 Apr; 68():771-94. PubMed ID: 14159018
[No Abstract] [Full Text] [Related]
12. [CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY].
MENCI S
Gazz Int Med Chir; 1964 Jan; 68():98-109. PubMed ID: 14123796
[No Abstract] [Full Text] [Related]
13. [Clinical observations and electrocardiography at rest and during exercise in coronary disease patients subjected to treatment with phenyl-propyldiphenylpropyl-amine].
CORNAGLIA M; MONTEVERDE A
Minerva Med; 1963 Apr; 54():1182-8. PubMed ID: 14023048
[No Abstract] [Full Text] [Related]
14. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
CESARI L
Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
[No Abstract] [Full Text] [Related]
15. [CATECHOLAMINE EXCRETION AND THE CLINICAL PICTURE IN THE MANAGEMENT OF CARDIAC INFARCTION AND CORONARY INSUFFICIENCY WITH N 3-PHENYLPROPYL -(2) 1, 1-DIPHENYL-PROPYL-(3)-AMINE].
GAWELLEK F; ECKERT H
Dtsch Gesundheitsw; 1964 Jul; 19():1339-46. PubMed ID: 14243103
[No Abstract] [Full Text] [Related]
16. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
DELLA PORTA P; LUCCHINI CR
Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of a preparation with antistenocardiac action, 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
PRETOLANI E
Gazz Int Med Chir; 1963 May; 67():1011-21. PubMed ID: 13986080
[No Abstract] [Full Text] [Related]
18. [Apropos of the use of "Segontin" in coronary patients].
Arnoux E; Boutin C; Ohresser P; Olmer M; Luccioni L; Bory M
Arch Med Gen Trop; 1965; 42(4):203-16. PubMed ID: 5846359
[No Abstract] [Full Text] [Related]
19. [Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
MIGHELI B; ANSELMINO A; BERT G; ANFOSSI F; BIANCO A; PUPITA F
Clin Ter; 1963 Mar; 24():530-42. PubMed ID: 13935671
[No Abstract] [Full Text] [Related]
20. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN HEALTHY PERSONS AND IN PATIENTS WITH ISCHEMIC HEART DISEASES. 3. CRITICAL EXAMINATION OF THE RESULTS AND CONCLUSIVE CONSIDERATIONS].
ZOLI A; BRAT A; GIARDINA A
Riv Crit Clin Med; 1963 Aug; 63():174-98. PubMed ID: 14192243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
